clinical trial · NCT06143839
VYxeoS Liposomal Italian Observational Study iN the Real Practice
Acute Myeloid Leukemia (AML)Acute Myeloid Leukemia With Myelodysplasia-Related ChangesTherapy-Related Acute Myeloid LeukemiaVyxeos liposomal
brief summary
The study is a prospective, single-arm, non-experimental, observational study in patients in Italy with Acute Myeloid Leukaemia (AML) with myelodysplastic-related changes or therapy related AML initiating treatment with JZP351 (Vyxeos liposomal) in their normal clinical practice.
started
Dec 7, 2023
primary completion
Oct 23, 2025
completion
Oct 23, 2025
last updated
Nov 20, 2025
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol